Works about HER2 gene
Results: 894
HER2 Amplification and Overexpression Is Not Present in Pediatric Osteosarcoma: A Tissue Microarray Study.
- Published in:
- Pediatric & Developmental Pathology, 2005, v. 8, n. 5, p. 525, doi. 10.1007/s10024-005-0044-5
- By:
- Publication type:
- Article
Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma.
- Published in:
- Histochemistry & Cell Biology, 2015, v. 143, n. 1, p. 1, doi. 10.1007/s00418-014-1258-2
- By:
- Publication type:
- Article
Generation of an enriched pool of DNA aptamers for an HER2-overexpressing cell line selected by Cell SELEX.
- Published in:
- Biotechnology & Applied Biochemistry, 2011, v. 58, n. 4, p. 226, doi. 10.1002/bab.36
- By:
- Publication type:
- Article
Chemotherapy de-escalation using an 18 F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain).
- Published in:
- Breast Cancer Research Review, 2021, n. 35, p. 3
- By:
- Publication type:
- Article
ELISA and Fourier-transform infrared spectroscopy: HER2 gene expression in the blood serum of canines with a mammary tumour.
- Published in:
- Veterinarska Stanica, 2022, v. 53, n. 4, p. 389, doi. 10.46419/vs.53.4.4
- By:
- Publication type:
- Article
Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv136
- By:
- Publication type:
- Article
Everything Old is Neu Again: Cellular Senescence in HER2-Positive Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 5, p. 1, doi. 10.1093/jnci/djv091
- By:
- Publication type:
- Article
Effect of Cellular Senescence on the Growth of HER2-Positive Breast Cancers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 5, p. 1, doi. 10.1093/jnci/djv020
- By:
- Publication type:
- Article
New Peptide Vaccine for HER2-Expressing Breast Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 2, p. 1, doi. 10.1093/jnci/djv022
- By:
- Publication type:
- Article
HER2-Positive Breast Cancer, Intrinsic Subtypes, and Tailoring Therapy.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 5, p. 406, doi. 10.1093/jnci/djr543
- By:
- Publication type:
- Article
How Do You Tell Whether a Breast Cancer is HER2 Positive? Ongoing Studies Keep Debate in High Gear.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 2, p. 87, doi. 10.1093/jnci/djq557
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2009
- Publication type:
- Correction Notice
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 10, p. 736, doi. 10.1093/jnci/djp082
- By:
- Publication type:
- Article
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 8, p. 628, doi. 10.1093/jnci/djk134
- By:
- Publication type:
- Article
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti--HER-2 Therapy and Personalized Medicine.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 320, doi. 10.1634/theoncologist.2008-0230
- By:
- Publication type:
- Article
Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management.
- Published in:
- Oncologist, 2008, v. 13, n. 8, p. 838, doi. 10.1634/theoncologist.2008-0048
- By:
- Publication type:
- Article
Central Nervous System Metastases in HER-2--Overexpressing Metastatic Breast Cancer: A Treatment Challenge.
- Published in:
- Oncologist, 2008, v. 13, n. 7, p. 739, doi. 10.1634/theoncologist.2008-0052
- By:
- Publication type:
- Article
Achieving Higher Pathological Complete Response Rates in HER-2--Positive Patients With Induction Chemotherapy Without Trastuzumab in Operable Breast Cancer.
- Published in:
- Oncologist, 2007, v. 12, n. 4, p. 390, doi. 10.1634/theoncologist.12-4-390
- By:
- Publication type:
- Article
Chromogenic In Situ Hybridization to Detect HER-2/neu Gene Amplification in Histological and ThinPrep-Processed Breast Cancer Fine-Needle Aspirates: A Sensitive and Practical Method in the Trastuzumab Era.
- Published in:
- Oncologist, 2006, v. 11, n. 8, p. 878, doi. 10.1634/theoncologist.11-8-878
- By:
- Publication type:
- Article
Liver resection for HER2-enriched breast cancer metastasis: case report and review of the literature.
- Published in:
- Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0307-1
- By:
- Publication type:
- Article
Effect of rapamycin on mRNA expression of IL-8 and CXCR1 in HER2+ breast cancer cells.
- Published in:
- Turkish Journal of Immunology, 2016, v. 4, p. 62
- By:
- Publication type:
- Article
Chromogenic in situ hybridization analysis ofHER-2/neu status in breast carcinoma: Application in screening of patients for trastuzumab (Herceptin[sup ®]) therapy.
- Published in:
- Pathology International, 2001, v. 51, n. 8, p. 579, doi. 10.1046/j.1440-1827.2001.01255.x
- By:
- Publication type:
- Article
Neratinib enhances the efficacy of CDK4/6 inhibitor plus endocrine therapy in HR<sup>+</sup>/HER2-low breast cancer cell line ZR-75-1 via hsa-miR-23a-5p.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-82137-9
- By:
- Publication type:
- Article
Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00354
- By:
- Publication type:
- Article
Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00212
- By:
- Publication type:
- Article
Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
- Published in:
- Case Reports in Gastrointestinal Medicine, 2015, v. 2015, p. 1, doi. 10.1155/2015/132030
- By:
- Publication type:
- Article
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.
- Published in:
- Oncogene, 2015, v. 34, n. 26, p. 3413, doi. 10.1038/onc.2014.272
- By:
- Publication type:
- Article
Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results.
- Published in:
- Animals (2076-2615), 2024, v. 14, n. 18, p. 2625, doi. 10.3390/ani14182625
- By:
- Publication type:
- Article
Protective Effect of HER2 Gene Polymorphism rs24537331 in the Outcome of Canine Mammary Tumors.
- Published in:
- Animals (2076-2615), 2023, v. 13, n. 8, p. 1384, doi. 10.3390/ani13081384
- By:
- Publication type:
- Article
Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Trastuzumab for the Treatment of HER2-Positive Metastatic Gastric Cancer.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 3, p. 185, doi. 10.1007/s40273-013-0023-z
- By:
- Publication type:
- Article
Prognostic value of ERBB family mRNA expression in breast carcinomas.
- Published in:
- International Journal of Cancer, 2003, v. 106, n. 5, p. 758, doi. 10.1002/ijc.11273
- By:
- Publication type:
- Article
A Novel Signature Based on Angiogenesis-Related Genes Predicts the Prognosis and Immunotherapy Response in HER2-Positive Breast Cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 14, p. 4731, doi. 10.7150/jca.94120
- By:
- Publication type:
- Article
Genomic Alterations Correlated to Trastuzumab Resistance and Clinical Outcomes in HER2+/HR- Breast Cancers of Patients Living in Northwestern China.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 14, p. 4467, doi. 10.7150/jca.84832
- By:
- Publication type:
- Article
Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 18, p. 3477, doi. 10.7150/jca.88446
- By:
- Publication type:
- Article
A BRIEF REVIEW ON HER-2 GENE IN VARIOUS CANCERS.
- Published in:
- Pharma Science Monitor, 2021, v. 12, n. 4, p. 34
- By:
- Publication type:
- Article
Detection of Amplified Her2 / Neu Gene Score 2 Cases in Breast Cancer Using Chromogenic In Situ Hybridization.
- Published in:
- Indian Journal of Public Health Research & Development, 2019, v. 10, n. 5, p. 1255, doi. 10.5958/0976-5506.2019.01168.9
- By:
- Publication type:
- Article
Neratinib, an irreversible erbB receptor tyrosine kinase inhibitor, in patients with advanced erbB2-positive breast cancer.
- Published in:
- Advances in Oncology, 2010, v. 5, n. 2, p. 21
- By:
- Publication type:
- Article
HER2 positive breast carcinomas: Four unusual cases.
- Published in:
- Canadian Journal of Pathology, 2017, v. 9, p. 34
- By:
- Publication type:
- Article
False-Positive FISH for HER2 Amplification in a Breast Cancer Owing to Loss of CE P17: A Case Report and Literature Review.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Evolution of HER2 Testing in Canada.
- Published in:
- Canadian Journal of Pathology, 2013, v. 5, n. 1, p. 8
- By:
- Publication type:
- Article
HER2 Testing in Canada: A Passing Grade.
- Published in:
- Canadian Journal of Pathology, 2013, v. 5, n. 1, p. 4
- By:
- Publication type:
- Article
The good and bad of ERBB receptors in breast - quanno viniti mi s'allarga lu cori, ma quanno vinni iti puru.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
New Trials Highlight Breast Cancer Therapy and Prevention.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 5, p. 453, doi. 10.1001/jama.2013.286122
- By:
- Publication type:
- Article
Rebooting Cancer Tissue Handling in the Sequencing Era.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Monitoring Src status after dasatinib treatment in HER2+ breast cancer with <sup>89</sup>Zr-trastuzumab PET imaging.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
- Published in:
- 2017
- By:
- Publication type:
- journal article